Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis

Serine Avagyan, Francesca Aguilo, Kenjiro Kamezaki, Hans-Willem Snoeck

Blood (2011) 118 (23): 6078–6086.

https://doi.org/10.1182/blood-2011-07-365080

Published: 2011

Includes: Supplemental data

Journal Articles

Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro

Kenjiro Kamezaki, MD, PhD, Hans-Willem Snoeck, MD, PhD

Blood (2011) 118 (21): 2450.

https://doi.org/10.1182/blood.V118.21.2450.2450

Published: 2011

Journal Articles

Prdm16 is a physiologic regulator of hematopoietic stem cells

Francesca Aguilo, Serine Avagyan, Amy Labar, Ana Sevilla, Dung-Fang Lee, Parameet Kumar, Ihor R. Lemischka, Betty Y. Zhou, Hans-Willem Snoeck

Blood (2011) 117 (19): 5057–5066.

https://doi.org/10.1182/blood-2010-08-300145

Published: 2011

Journal Articles

Transforming growth factor-β2 is involved in quantitative genetic variation in thymic involution

Ritu Kumar, Jessica C. Langer, Hans-Willem Snoeck

Blood (2006) 107 (5): 1974–1979.

https://doi.org/10.1182/blood-2005-04-1495

Published: 2006

Journal Articles

Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice

Els Henckaerts, Jessica C. Langer, Hans-Willem Snoeck

Blood (2004) 104 (2): 374–379.

https://doi.org/10.1182/blood-2003-12-4304

Published: 2004

Journal Articles

Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines

Els Henckaerts, Hartmut Geiger, Jessica C. Langer, Patricia Rebollo, Gary Van Zant, Hans-Willem Snoeck

Blood (2002) 99 (11): 3947–3954.

https://doi.org/10.1182/blood.V99.11.3947

Published: 2002

NARROW

Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis

Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro

Prdm16 is a physiologic regulator of hematopoietic stem cells

Transforming growth factor-β2 is involved in quantitative genetic variation in thymic involution

Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice

Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines

Email alerts

ASH Publications

American Society of Hematology

Quantitative trait mapping reveals a regulatory axis involving peroxisome proliferator-activated receptors, PRDM16, transforming growth factor-β2 and FLT3 in hematopoiesis

Flt3 Is Required for MLL-ENL-Induced Leukemogenesis In Vivo, but Not for LSC Function in Vitro

Prdm16 is a physiologic regulator of hematopoietic stem cells

Transforming growth factor-β2 is involved in quantitative genetic variation in thymic involution

Quantitative genetic variation in the hematopoietic stem cell and progenitor cell compartment and in lifespan are closely linked at multiple loci in BXD recombinant inbred mice

Genetically determined variation in the number of phenotypically defined hematopoietic progenitor and stem cells and in their response to early-acting cytokines

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only